TACC1 Antibodies

Santa Cruz Biotechnology provides a broad selection of TACC1 monoclonal antibodies for investigating TACC1 in cellular processes. TACC1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TACC1, or Transforming Acidic Coiled-Coil 1, is a crucial component involved in cell division and the maintenance of genomic stability. TACC1 plays a significant role in the regulation of microtubule dynamics during cellular processes. Research has shown that TACC1 expression is altered in various cancers, making it an important target for cancer research. Understanding TACC1 function can provide insights into tumorigenesis and potential therapeutic strategies. Investigating TACC1 expression patterns helps researchers uncover its role in normal development and disease progression. TACC1 research continues to reveal new insights about cell cycle regulation and cancer biology. Santa Cruz Biotechnology monoclonal antibodies for TACC1 support researchers worldwide in advancing scientific understanding of cancer mechanisms and potential treatments.